Triple-negative breast cancer (TNBC) occurs in 12–17% of breast cancer and is a subtype that does not express estrogen receptor (ER), progesterone receptor (PR) or human epidermal growth factor receptor 2 (HER2) (Foulkes et al. 2010). Here, PGR is linked to triple-negative breast carcinoma.